Robot vs. robot: which bronchoscope best spots lung trouble?
NCT ID NCT07735611
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This trial compares two FDA-cleared robotic bronchoscopy platforms—Monarch and ION—to see which one better diagnoses suspicious spots in the lungs. About 400 people scheduled for a robotic bronchoscopy will be randomly assigned to one of the two systems. The main question is which platform more often successfully collects tissue from the target lesion for diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- robotic-assisted bronchoscopy via the Monarch platform or the ION platform
- What this could lead to
- If one platform proves more effective, it could become the preferred tool for diagnosing suspicious lung spots, potentially improving early detection.
- What could go wrong
- This trial compares two already-approved devices, so the difference may be small. Results depend on operator skill and lesion characteristics, which could limit generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG; NODE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Cleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.